Powering Discovery at Scale

EMPOWER: To Push Further Than Ever Before

Scientific ambition has always outpaced technological capability. Today, advances in high-throughput proteomics, analytical performance, and computational biology are closing that gap, enabling researchers to design larger studies, generate deeper biological insights, and answer increasingly complex questions with greater confidence.

In this second chapter of the Ride the Wave: Innovation Now for Precision Health webinar series, you'll hear from scientists who are exploring what it will take for proteomics to reach its full translational potential. Through complementary perspectives on emerging capabilities and scalable workflows, they'll examine how the field is overcoming long-standing barriers and what still needs to happen to make large-scale translational proteomics routine.

Featured Speakers

• Philipp Geyer What Would It Take? Rethinking the Capabilities Translational Proteomics Actually Needs

Dr. Philipp Geyer will explore what it will take for proteomics to fully realize its translational potential. Drawing on his experience building technologies in both academia and industry, he will examine the capability gaps that still stand between today's advances and tomorrow's clinical impact.

• Markku Varjosalo High-Throughput Proteomics, Driving the Next Wave of Translational Research

Dr. Markku Varjosalo will explore how advances in high-throughput proteomics are transforming the field from boutique measurements to robust, scalable workflows capable of supporting large translational research cohorts. He will discuss what makes throughput reliable, not just fast, and what is still needed to make large-scale proteomics routine.

What You'll Learn

• Explore how advances in proteomics are enabling larger, more ambitious translational studies.
• Understand how leading researchers are applying new analytical capabilities to generate deeper biological insights.
• Leave with a new perspective on what's now possible through modern proteomics.

Presenter:  Philipp Geyer, PhD (Chief Scientific Officer, Managing Director, Ions.Bio)

Dr. Philipp Geyer is a Founder, Chief Scientific Officer, and Managing Director of ions.bio. His research develops mass spectrometry-based plasma proteomics and AI-driven biomarker discovery workflows to accelerate precision medicine and clinical diagnostics. He is a pioneer in high-throughput plasma proteomics and translating proteomics technologies into real-world healthcare applications.

Presenter: Markku Varjosalo, PhD (Research Director, University of Helsinki)

Dr. Markku Varjosalo, is a Research Director at the Institute of Biotechnology, University of Helsinki, where he leads the Molecular Systems Biology research group. His research combines innovative proteomics technologies, computational biology, and systems biology to overcome the barriers that have traditionally limited large-scale proteomics. Through the development of robust, high-throughput workflows, Dr. Varjosalo is helping empower researchers to tackle increasingly ambitious translational studies

Moderator: Stephanie Samra (Sr. Manager, Translational Research, Thermo Fisher Scientific)

Stephanie Samra is the Senior Market Development Manager for the Translational Research Program at Thermo Fisher Scientific, where she leads global market development initiatives supporting the translational proteomics community. With more than 15 years of experience in analytical chemistry and mass spectrometry, she specializes in LC-MS/MS workflows spanning metabolomics, clinical research, and translational science. As host of the Ride the Wave webinar series, Stephanie brings together leading researchers to explore the bold ideas, enabling technologies, and transformational discoveries shaping the future of precision health.